ClinicalTrials.gov
ClinicalTrials.gov Menu

Brow Enhancement Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01308593
Recruitment Status : Completed
First Posted : March 4, 2011
Last Update Posted : January 4, 2013
Sponsor:
Information provided by (Responsible Party):
Derek H. Jones, M.D., Skin Care and Laser Physicians of Beverly Hills

Brief Summary:
Investigation into brow aesthetics using Botox in Conjunction with Juvederm XC as evaluated by patient satisfaction

Condition or disease Intervention/treatment Phase
Brow Ptosis Device: Juvederm XC Drug: Botox Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Investigation Into Brow Aesthetics Using Botox in Conjunction With Juvederm Ultra XC as Evaluated by Patient Satisfaction
Study Start Date : March 2011
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Botox

Arm Intervention/treatment
Active Comparator: Juvederm XC
Juvederm XC
Device: Juvederm XC
Filler

Active Comparator: Botox
Medication used to block neuromuscular transmission
Drug: Botox
26 units dosed one time




Primary Outcome Measures :
  1. Participant satisfaction with combined injection with Botox and Juvederm XC [ Time Frame: 5 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Men and women

Exclusion Criteria:

  • Persons who have not had Botox for months.
  • Women who are pregnant, breastfeeding, or trying to get pregnant.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01308593


Locations
United States, California
Skin Care and Laser Physicians of Beverly Hills
Los Angeles, California, United States, 90069
Sponsors and Collaborators
Skin Care and Laser Physicians of Beverly Hills

Responsible Party: Derek H. Jones, M.D., Principal Investigator, Skin Care and Laser Physicians of Beverly Hills
ClinicalTrials.gov Identifier: NCT01308593     History of Changes
Other Study ID Numbers: Brow Study 25856/1
First Posted: March 4, 2011    Key Record Dates
Last Update Posted: January 4, 2013
Last Verified: January 2013

Additional relevant MeSH terms:
onabotulinumtoxinA
Acetylcholine Release Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cholinergic Agents
Neurotransmitter Agents
Physiological Effects of Drugs